Schizophrenia trials in Türkiye
2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Where
- Ankara, Atakum, Eskişehir, Istanbul, Izmir
- Age
- 55 years to 90 years
- People
- 406 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00 - No phaseTaking peopleSpeech-based Assessment of Relapse Risk in People With Psychosis
- Where
- Izmir
- Age
- 18 years to 65 years
- People
- 360 worldwide
- Run by
- Philipp Homan
See details and how to joinNCT07397975